360 Financial’s Asensus Surgical, Inc. ASXC Stock Holding History

360 Financial’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,919	Closed	-$5K	–	94
2022 Q2	$5K	Buy	+10,919	New	+$4.87K	﹤0.01%	81
2022 Q1	–	Sell	-10,127	Closed	-$11K	–	105
2021 Q4	$11K	Sell	10,127 -408	-4%	-$630	0.01%	92
2021 Q3	$19K	Hold	10,535	–	–	0.01%	90
2021 Q2	$33K	Buy	+10,535	New	+$26.3K	0.02%	90

Other funds holding ASXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

360 Financial's ASXC Position: Q3 2022 in Review

360 Financial sold out of Asensus Surgical, Inc. (ASXC) in Q3 2022, closing a stake of 10,919 shares — an estimated $5K sold.

360 Financial first reported a position in ASXC in Q2 2021 and held it in 4 quarters. The position peaked at $33K in Q2 2021. 82 funds tracked by Wall St. Rank hold ASXC as of Q3 2022.

360 Financial reported no remaining Asensus Surgical, Inc. position as of Q3 2022 after selling out during the quarter.
360 Financial sold 10,919 Asensus Surgical, Inc. shares in Q3 2022, an estimated $5K.
360 Financial first reported a position in Asensus Surgical, Inc. in Q2 2021 and held it in 4 quarters.
360 Financial's Asensus Surgical, Inc. position peaked at $33K in Q2 2021.
82 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2022.

Based on 360 Financial's 13F filing for Q3 2022, filed 19 Oct 2022.